Hofseth Biocare ASA
Research Hofseth Biocare ASA (HBC) on Bullrun: market cap NOK 723.91M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHBC
- ExchangeOL
- CountryNorway
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyNOK
- Market capNOK 723.91M
- Financial periodQ1 2026
- RevenueNOK 49.48M
- Net income-NOK 36.57M
- Free cash flow-NOK 24.61M
- Gross margin40.8%
Valuation Snapshot
latest market cap is NOK 723.91M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | NOK 256.34M | -NOK 134.88M | -NOK 41.66M | 37.2% | -0.33 | NOK 63.28M | NOK 359.94M | -NOK 74.84M |
| FY2024 | NOK 256.83M | -NOK 125.30M | -NOK 12.22M | 34.0% | -0.3 | NOK 25.58M | NOK 73.12M | NOK 59.36M |
| FY2023 | NOK 190.82M | -NOK 106.68M | -NOK 5.43M | 21.0% | -0.27 | NOK 23.89M | NOK 29.16M | NOK 41.14M |
| FY2022 | NOK 119.13M | -NOK 137.39M | -NOK 49.19M | 22.8% | -0.37 | NOK 32.43M | NOK 1.35M | NOK 148.03M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-28 | NOK 723.91M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 NOK.
About Hofseth Biocare ASA
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Hofseth Biocare ASA's market cap?
Hofseth Biocare ASA's market capitalization is NOK 723.91M.
What does Hofseth Biocare ASA do?
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.